menu search

GDRX / GoodRx's Integrative Growth Strategy Inches Towards Sustained Profitability

GoodRx's Integrative Growth Strategy Inches Towards Sustained Profitability
The company's integrated pharmaceutical platform, accretive growth through disciplined M&A, and undervaluation lead to a 'buy' rating. With a fair value of $6.30, averaged between my DCF and Alpha Spread's relative valuation, the stock is undervalued by 9%. GoodRx's value proposition relies on network-effect-driven scale and integrative growth, with its acquisition of VitaCare and expansion into multiple consumer-facing verticals. Read More
Posted: Jun 20 2023, 19:54
Author Name: Seeking Alpha
Views: 122473

GDRX News  

GoodRx to offer Sanofi's insulin injection for only $35

By Reuters
October 19, 2023

GoodRx to offer Sanofi's insulin injection for only $35

GoodRx said on Thursday it has collaborated with Sanofi to offer the drugmaker's most-prescribed insulin injection Lantus for only $35 through its dig more_horizontal

GoodRx Faces Challenges In Subscription Plans, But Its Valuation Already Prices This In

By Seeking Alpha
September 27, 2023

GoodRx Faces Challenges In Subscription Plans, But Its Valuation Already Prices This In

GoodRx's investment thesis is positive. The company's near-term prospects are promising. GoodRx is experiencing strong revenue growth rates. more_horizontal

GoodRx Stock: Earnings Momentum Keeps It Interesting

By Seeking Alpha
September 26, 2023

GoodRx Stock: Earnings Momentum Keeps It Interesting

GoodRx is generating solid profitability with growth in monthly active consumers to its prescription drugs discount platform. Management expects stron more_horizontal

ICLR vs. GDRX: Which Stock Is the Better Value Option?

By Zacks Investment Research
September 21, 2023

ICLR vs. GDRX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or GoodRx Holdings, Inc. (GDRX). But which o more_horizontal

Down -11.5% in 4 Weeks, Here's Why You Should You Buy the Dip in GoodRx Holdings, Inc. (GDRX)

By Zacks Investment Research
September 19, 2023

Down -11.5% in 4 Weeks, Here's Why You Should You Buy the Dip in GoodRx Holdings, Inc. (GDRX)

The heavy selling pressure might have exhausted for GoodRx Holdings, Inc. (GDRX) as it is technically in oversold territory now. In addition to this t more_horizontal

ICLR vs. GDRX: Which Stock Should Value Investors Buy Now?

By Zacks Investment Research
September 5, 2023

ICLR vs. GDRX: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical Services sector have probably already heard of Icon PLC (ICLR) and GoodRx Holdings, Inc. (GDRX). But w more_horizontal

ICLR or GDRX: Which Is the Better Value Stock Right Now?

By Zacks Investment Research
August 18, 2023

ICLR or GDRX: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical Services sector might want to consider either Icon PLC (ICLR) or GoodRx Holdings, Inc. (GDRX). But which o more_horizontal

GoodRx Holdings, Inc. (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

By Zacks Investment Research
August 9, 2023

GoodRx Holdings, Inc. (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for GoodRx Holdings, Inc. (GDRX) give a sense of how the business performed in the quarter ended June 2023, it more_horizontal


Search within

Pages Search Results: